Patients with HER2-positive breast cancer in the FLAMINGO-01 phase 3 clinical trial are seeing a continued reduction in recurrence rates, Greenwich LifeSciences, Inc. has reported. The preliminary ...

Sigma has announced two new F1.4 lenses for Indian photographers—the 15mm F1.4 DC | Contemporary for APS-C shooters and the 35mm F1.4 DG II | Art for .

Pune: To raise awareness about thalassaemia and provide life-saving treatment opportunities for affected children, a free bone marrow cross-matching camp will be held at the District Hospital in Aundh ...

Use of a clinician-facing dashboard combined with a best practice alert helped increase rates of HLA-B*58:01 genetic testing among patients prescribed allopurinol.

Immatics N.V. remains a speculative Buy, driven by progress with anzu-cel in 2L melanoma and a robust cell therapy pipeline.

CareDx (NASDAQ:CDNA) executives outlined the company’s transplant-focused strategy, recent financial performance, and 2026 priorities during remarks at the Raymond James Institutional Investor ...

A hidden donor-recipient HLA mismatch may increase the risk of life-threatening immune complications after cord blood ...

On Tuesday, 03 March 2026, CareDx (NASDAQ:CDNA) presented at the 47th Annual Raymond James Institutional Investor Conference. The company outlined its strategic focus on expanding its transplant ...

CareDx reported strong Q4 2025 revenue growth of 25% year-over-year, reaching $108 million. The company is expanding its Transplant+ strategy to include hematologic cancers with the AlloHeme test.